Press Releases

Read: BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany

BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany

• Nov 2, 2021

Read: AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design

AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design

• Oct 19, 2021

Read: AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

• Oct 13, 2021

Read: BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen

BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen

• Aug 2, 2021

Read: BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology

BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology

• Jul 5, 2021

Read: BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity

BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity

• May 17, 2021

Read: BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim

BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim

• Mar 29, 2021

Read: BioMed X Institute starts new research project in drug delivery in collaboration with Janssen

BioMed X Institute starts new research project in drug delivery in collaboration with Janssen

• Jan 26, 2021

Read: BioMed X Institute completes first research project in neuroscience with Boehringer Ingelheim

BioMed X Institute completes first research project in neuroscience with Boehringer Ingelheim

• Dec 8, 2020

Read: BioMed X Institute announces expansion of their strategic collaboration with Janssen in immunology research

BioMed X Institute announces expansion of their strategic collaboration with Janssen in immunology research

• Nov 9, 2020

Read: BioMed X Institute launches Rapid Antiviral Response Platform to prevent future pandemics

BioMed X Institute launches Rapid Antiviral Response Platform to prevent future pandemics

• May 13, 2020

Read: BioMed X starts new schizophrenia research program with Boehringer Ingelheim

BioMed X starts new schizophrenia research program with Boehringer Ingelheim

• Jan 13, 2020

Read: BioMed X starts new research program in autoimmune diseases with Merck

BioMed X starts new research program in autoimmune diseases with Merck

• Jan 9, 2020

Read: BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases

• Jan 17, 2019

Read: BioMed X and Merck extend research collaboration in oncology

BioMed X and Merck extend research collaboration in oncology

• May 8, 2018

Read: BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity

BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity

• Nov 27, 2017

Read: BioMed X Announces Biomedical Research Collaboration with Janssen

BioMed X Announces Biomedical Research Collaboration with Janssen

• Oct 25, 2017

Read: BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing

BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing

• Jun 8, 2017

Read: BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity

BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity

• Feb 6, 2017

Read: BioMed X and Merck start new project in cancer research

BioMed X and Merck start new project in cancer research

• Nov 3, 2016

Read: BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation

BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation

• Sep 6, 2016